| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $37.6M | -10.1% |
| SG&A Expense | $13.8M | +25.2% |
| Operating Income | -$51.4M | +2.8% |
| Pre-tax Income | -$46.4M | -7.8% |
| Net Income | -$46.4M | -7.8% |
| EPS (Basic) | -$0.54 | -3.8% |
| EPS (Diluted) | -$0.54 | -3.8% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.6M | -22.4% |
| Total Assets | $103.8M | -23.4% |
| Total Liabilities | $8.9M | -41.5% |
| Stockholders' Equity | $94.9M | -21.1% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.0M | -26.7% |
| Financing Cash Flow | $9.4M | -21.2% |